Abstract
Inflammation in the periphery often leads to pathological pain processes such as allodynia (reduction in pain threshold), hyperalgesia (increased response to noxious stimuli), persistent pain (increase in the duration of the response to a brief stimulation) and secondary hyperalgesia (a spread of pain and hyperalgesia to non-inflamed tissue). Increased pain in response to stimulation during inflammation depends on both an increase in sensitivity of primary afferent nociceptors at the site of inflammation and an increase in the excitability of neurones in the central nervous system (CNS; i.e. peripheral and central sensitisation respectively). The following chapter discusses the probable role of nitric oxide (NO) in both peripheral, and especially, central sensitisation evoked by an inflammatory response. A brief overview of NO synthesis, biological effects and isoforms is provided in order to examine the extent of NO mediated pathophysiological responses during inflammatory pain.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Palmer RMJ, Ashton DS, Moncada S (1988) Vascular endothelial cells synthesise nitric oxide from L-arginine. Nature 333: 664–666
Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide: physiology pathophysiology and pharmacology. Pharmacol Rev 43: 109–142
Liu Q, Gross SS (1996) Binding sites of nitric oxide synthases. In: L Packer (ed): Methods in enzymology 268. Academic Press, London, 311–323
Katsuki S, Arnold W, Mittal C, Murad F (1977) Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin, and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J Cyclic Nuc Res 3: 23–35
Gruetter CA, Gruetter DY, Lyon JE, Kadowitz PJ, Ignarro LJ (1981) Relationship between cyclic 3’:5’-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinirate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin. J Pharm Exp Ther 219: 181–186
Mellion BT, Ignarro LJ, Ohlstein EH, Pontecarvo EG, Hyman AL, Kadowitz PJ (1981) Evidence for the inhibitory role of guanosine 3’:5’-monophosphate in ADP induced human platelet aggregation in the presence of nitric oxide and related vasdilators. Blood 57: 946–955
Garthwaite J, Charles SL, Chess-Williams R (1988) Endothelium derived relaxing factor on activation of NMDA receptors suggests a role as intercellular messanger in the brain. Nature 336: 385–388
Wink DA, Osawa Y, Darbyshire JF, Jones CR, Eshenaur SC, Nims RW (1993) Inhibition of cytochromes P450 by nitric oxide and a nitric-oxide releasing agent. Arch Biochem Biophys 300: 115–123
Kanner J., Harel S, Granit R (1992) Nitric oxide, an inhibitor of lipid oxidation by lipoxygenase, cyclooxygenase and hemoglobin. Lipids 27: 46–47
Lepoivre M, Fieschi F, Coves J, Thelander L, Fontecave M (1991) Inactivation of ribonucleotide reductase by nitric oxide. Biochem Biophys Res Commun 179: 442–448
Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Needleman P (1993) Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 90: 7240–7244
Salvemini D, Manning PT, Zweifel BS, Seibert K, Connor J, Currie MG, Needleman P, Masferrer JL (1995) Dual Inhibition of nitric-oxide and prostaglandin production contributes to the antiinflammatory properties of nitric-oxide synthase inhibitors. J Clin Invest 96: 301–308
Sautebin L, Ialenti A, Ianaro A, DiRosa M (1995) Modulation by nitric oxide of prostaglandin biosynthesis in the rat. Br J Pharmacol 114: 323–328
Gross SS, Wolin MS (1995) Nitric oxide: pathophysiological mechanisms. Ann Rev Physiol 57: 737–769
Darley-Usmar V, Halliwell B (1996) Blood radicals: reactive nitrogen species, reactive oxygen species, transition metal ions, and the vascular system. Pharm Res 13: 649–662
Bredt DS, Snyder SH (1990) Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 87: 682–685
Mayer B, John M, Bohme E (1990) Purification of a calcium/calmodulin-dependant nitric oxide synthase from porcine cerebellum. Co-factor role of tetrahydrobiopterin. FEBS Lett 277: 215–219
Schmidt HHHW, Pollock JS, Nakane M, Gorsky LD, Forstermann U, Murad F (1991) Purification of a soluble isoform of guanylyl cyclase-activating-factor synthase. Proc Natl Acad Sci USA 88: 365–369
Herdegen T, Brecht S, Mayer B, Leah J, Kummer W, Bravo R, Zimmermann M (1993) Long-lasting expression of JUN and KROX transcription factors and nitric oxide synthase in intrinsic neurons of the rat brain following axotomy. J Neurosci 13: 4130–4145
Hokfelt T, Ceccatelli S, Gustafsson L, Hulting AL, Verge V, Villar M, Xu XJ, Wiesenfeld-Hallin Z, Zhang X (1994) Plasticity of NO synthase expression in the nervous and endocrine systems. Neuropharmacol 33: 1221–1227
Verge VM, Xu Z, Xu X-J, Wiesenfeld-Hallin Z, Hokfelt T (1992) Marked increase in nitric oxide synthase mRNA in dorsal root ganglia after peripheral axotomy: In situ hybridisation and functional studies. Proc Natl Acad Sci USA 89: 11617–11621
Zhang ZG, Chopp M, Gautam S, Zaloga C, Zhang RL, Schmidt HHHW, Pollock JS, Forstermann U (1994) Upregulation of neuronal nitric oxide synthase and mRNA, and selective sparing of nitric oxide synthase-containing neurones after focal cerebral ischaemia in rat. Brain Res 654: 85–95
Kadowaki K, Kishimoto J, Leng G, Emson PC (1991) Upregulation of nitric oxide synthase (NOS) gene expression together with NOS activity in the rat hypothalamohypophysial system after chronic salt loading — arginine vasopressin and oxytocin secretion. Endocrinology 134: 1011–1017
Belvisi M, Barnes PJ, Larkin S, Yacoub M, Tadjkarimi S, Williams TJ, Mitchell JA (1995) Nitric oxide activity is elevated in inflammatory lung disease in humans. Eur J Pharmacol 283: 255–258
Ruan E, Otterson MF, Telford GL, Stryker SJ, Alexander C, Rao S, Koch TR (1995) Increased neuronal nitric oxide synthase activity in IBD appears to be related to inflammation. Gastroenterology 108: A1002
Nakane M, Mitchell J, Forstermann U, Murad F (1991) Phosphorylation by calciumcalmodulin dependant protein kinase II and protein kinase C modulates the activity of nitric oxide synthase. Biochem Biophys Res Commun 181: 1396–1402
Davda RK, Chandler LJ, Guzman NJ (1994) Protein kinase C modulates receptor-independent activation of endothelial nitric oxide synthase. Eur J Pharmacol 266: 237–244
Hevel JM, White KA, Marietta MA (1991) Purification of the inducible murine macrophage nitric oxide synthase. Identification as a flavoprotein. J Biol Chem 266: 22789–22791
Stuehr DJ, Cho HJ, Kwon NS, Weise MF, Nathan CF (1991) Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein. Proc Natl Acad Sci USA 88: 7773–7777
Kroncke K-D, Fehsel K, Kolb-Bachofen V (1995) Inducible nitric oxide synthase and its product nitric oxide, a small molecule with complex biological activities. Biol Chem Hoppe-Seyler 376: 327–343
Cho HJ, Xie QW, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Nathan C (1992) Calmodulin is a subunit of nitric oxide synthase from macrophages. J Exp Med 176: 599–604
Gross SS, Levi R (1992) Tetrahydrobiopterin synthesis - an absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. J Biol Chem 267: 25722–25729
Jorens PG, Vanoverveld FJ, Bult H, Vermeire PE, Herman AG (1992) Pterins inhibits nitric oxide synthase activity in rat alveolar macrophages. Br J Pharmacol 107: 1088–1091
Cattell V, Jansen A (1995) Inducible nitric oxide synthase in inflammation. Histochem J 27: 777–784
Lander HM, Schajpal PK, Novogrodsky A (1993) Nitric oxide signalling: z possible role for G proteins. J Immunol 151: 7182–7187
Marotta P, Sautebin L, DiRosa M (1992) Modulation of the induction of nitric oxide synthase eicosanoids in the murine macrophage cell line J774. Br J Pharmacol 107: 640–641
Nathan C, Xie QW (1994) Nitric oxide synthase: roles, tolls and controls. Cell 78: 915–918
Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnehher G, Wachter H (1990) Tetrahydrobioptein-dependent formation of nitrite and nitrate in murine fibroblasts. J Exp Med 172: 1599–1607
Gross SS, Jaffe EA, Levi R, Kilbourn RG (1991) Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages. Biochem Biophys Res Commun 178: 823–829
Boje KM, Fung HL (1990) Endothelial nitric oxide generating enzyme(s) in the bovine aorta: subcellular location and metabolic characterization. J Pharm Exp Ther 253: 20–26
Forstermann U, Pollock JS, Schmidt HH, Heller M, Murad F (1991) Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. Proc Natl Acad Sci USA 88: 239–257
Janssens SP, Shimouchi A, Quertermous T, Bloch DB, Bloch KD (1992) Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem 267: 14519–14522
Lamas S, Marsden PA, Li GK, Tempst P, Michel T (1992) Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA 89: 6348–6352
Sessa WC, Harrison JK, Barber CM, Zeng D, Durieux ME, D’Angelo DD, Lynch KR, Peach MJ (1992) Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. J Biol Chem 267: 15274–15276
Pollock JS, Nakane M, Buttery LDK, Martinez A, Springall D, Polak JM, Forstermann U, Murad F (1993) Characterization and localization of endothelial nitric oxide synthase using specific monoclonal antibodies. Am J Physiol 265: C1379–C1387
Myatt L, Brockman DE, Eis A, Pollock JS (1993) Immunohistochemical localization of nitric oxide synthase in the human placenta. Placenta 14: 487–495
Tracey WR, Pollock JS, Murad F, Nakane M, Forstermann U (1994) Identification of a type III (endothelial-like) particulate nitric oxide synthase in LLC-PK1 kidney tubular epithelial cells. Am J Physiol 266: C22–C26
Xue C, Pollock J, Schmidt HHHW, Ward SM, Sanders KM (1994) Expression of nitric oxide synthase immunoreactivity by interstitial cells of the canine proximal colon. J Auton Nery Syst 49: 1–14
Dinerman JL, Dawson TM, Schell MJ, Snowman A, Snyder SH (1994) Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: Implications for synaptic plasticity. Proc Natl Acad Sci USA 91: 4214–4218
Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S (1994) Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA 91: 5212–5216
Zhang ZG, Chopp M, Zaloga C, Pollock JS, Forstermann U (1993) Cerebral endothelial nitric oxide synthase expression after focal cerebral ischaemia in rats. Stroke 24: 2016–2021
Suschek C, Fehsel K, Kroncke KD, Sommer AVK-B (1994) Primary cultures of rat islet capillary endothelial cells. Constitutive and cytokine-inducible macrophage-like nitric oxide synthases are expressed and activities regulated by glucose concentration. Am J Pathol 145: 685–695
Pollock JS, Klinghofer V, Forstermann U, Murad F (1992) Endothelial nitric oxide synthase is myrisylated. FEBS Letts 309: 402–404
Pollock JS, Forstermann U, Mitchell JA, Warner TD, Schmidt HHHW, Nakane M, Murad F (1991) Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci USA 88: 10480–10484
Corson MA, Berk BC, Navas JP, Harrison DG (1993) Phosphorylation of endothelial nitric oxide synthase in response to shear stress. Circulation 88: 183–187
Moore PK, Oluyomi AO, Babbedge RC, Wallace P, Hart SL (1991) L-NG nitroarginine methyl ester exhibits antinociceptive activity in the mouse. Br J Pharmacol 102: 198–202
Dwyer MA, Bredt DS, Snyder SH (1991) Nitric oxide synthase: irreversible inhibition by L-NG nitroarginine in brain in vitro and in vivo. Biochem Biophys Res Commun 176: 1136–1141
Moore PK, Wallace P, Gaffen ZA, Hart SL, Babbedge RC (1993a) 7-nitroindazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure. Br J Pharmacol 108: 296–297
Moore PK, Wallace P, Gaffen Z, Hart SL, Babbedge RC (1993b) Characterization of the novel nitric oxide synthase inhibitor 7-nitroindazole and related indazoles: antinociceptive and cardiovascular effects. Br J Pharmacol 110: 219–224
Handy RLC, Wallace P, Gaffen ZA, Whitehead KJ, Moore PK (1995) The antinociceptive effect of 1-(2-trifluoromethylphenyl) imidazole (TRIM), a potent inhibitor of neuronal nitric oxide synthase in vitro, in the mouse. Br J Pharmacol 116: 2349–2350
Corbett JA, Tilton RG, Chang K, Hasan KS, Ido Y, Wang JL, Sweetland MA, Lancaster JR, Williamson JR, McDaniel ML (1992) Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41: 552–556
Moore WM, Webber RK, Jerome GM, Tjoeng FS, Misko TP, Currie MG (1994) L-N6(1-Iminoethyl)lysine: A selective inhibitor of inducible nitric oxide synthase. J Med Chem 37: 3886–3888
Bieganski T, Osinska Z, Maslinski C (1982) Inhibition of plant diamine oxidases by hydrazine and guanidine compounds. Int J Biochem 14: 949–953
Ou P, Wolff SP (1993) Aminoguanidine: a drug proposed for prophylaxis in diabetes inhibits catalase and generates hydrogen peroxide in vitro. Biochem Pharmacol 46: 1139–1144
Zhang ZG, Reif D, MacDonald J, Tang WX, Kamp DK, Gentile RJ, Shakespeare WC, Murray RJ, Chopp M (1996) ARL 17477, a potent and selective neuronal NOS inhibitor decreases infarct volume after transient middle cerebral artery occlusion in rats. J Cerebral Blood Flow & Metab 16: 599–604
Garvey EP, Oplinger JA, Furfine ES, Kiff RJ, Laszlo F, Whittle BJ, Knowles RG (1997) 1400W is a slow, tight binding, and highly selective inhibitor of it 3ucible nitric-oxide synthase in vitro and in vivo. J Biol Chem 272: 4959–4963
Moore PK, Handy RLC (1997) Therapeutic implications of isoform selective inhibition of nitric oxide synthase — or is no NOS really good NOS? Trends Pharmacol Sci 18: 204–211
Dun NJ, Dun SL, Wu SY, Forstermann U, Schmidt HHHW, Tseng LF (1993) Nitric oxide synthase immunoreactivity in the rat, mouse, cat and squirrel monkey spinal cord. Neuroscience 54: 845–857
Saito S, Kidd GJ, Trapp BD, Dawson TM, Bredt DS, Wilson DA, Traystman RJ, Snyder SH, Hanley DF (1994) Rat spinal cord neurons contain nitric oxide synthase. Neuroscience 59: 447–456
Herdegen T, Brecht S, Mayer B, Leah J, Kummer W, Bravo R, Zimmermann M (1993) Long-lasting expression of JUN and KROX transcription factors and nitric oxide synthase in intrinsic neurons of the rat brain following axotomy. J Neurosci 13: 4130–4145
Hokfelt T, Ceccatelli S, Gustagsson L, Hulting AL, Verge V, Villar M, Xu XJ, Wiesenfeld-Hallin Z, Zhang X (1994) Plasticity of NO synthase expression in the nervous and endocrine systems. Neuropharmacol 33: 1221–1227
Verge VM, Xu Z, Xu X-J, Wiesenfeld-Hallin Z, Hokfelt T (1992) Marked increase in nitric oxide synthase mRNA in dorsal root ganglia after peripheral axotomy: In situ hybridisation and functional studies. Proc Natl Acad Sci USA 89: 11617–11621
Lam HHD, Hanley DF, Trapp BD, Saito S, Raja S, Dawson TM, Yamaguchi H (1996) Induction of spinal cord neuronal nitric oxide synthase (NOS) after formalin injection in the rat hind paw. Neurosci Lett 210: 201–204
Solodkin A, Traub RJ, Gebhart GF (1992) Unilateral hindpaw inflammation produces a bilateral increase in NADPH-diaphorase histochemical staining in the rat lumbar spinal cord. Neuroscience 51: 495–499
Traub RJ, Solodkin A, Meller ST, Gebhart GF (1994) Spinal cord NADPH-diaphorase histochemical staining but not nitric oxide synthase immunoreactivity increases following carrageenan-produced hindpaw inflammation in the rat. Brain Res 668: 204–210
Garthwaite J, Charles SL, Chess-Williams R (1988) Endothelium derived relaxing factor on activation of NMDA receptors suggests a role as intercellular messanger in the brain. Nature 336: 385–388
Watkins JC, Evans RH (1981) Excitatory amino acid transmitters. Ann Rev Pharmacol Toxicol 21: 165–204
Aanonsen LM, Wilcox GL (1987) Nociceptive action of excitatory amino acids in the mouse: effects of spinally administered opioids, phencyclidine and sigma agonists. J Pharm Exp Ther 243: 9–19
Ren K, Hylden JLK, Williams G, Ruda MA, Dubner R (1992) The intrathecal administration of excitatory amino acid receptor antagonists selectively attenuated carrageenaninduced behavioural hyperalgesia in rats. Eur J Pharmacol 219: 235–243
Coderre TJ, Melzack R (1992) The role of NMDA receptor-operated calcium channels in persistent nociception after formalin-induced tissue injury. J Neurosci 12: 3671–3675
Malmberg AB, Yaksh TL (1993) Spinal nitric oxide synthesis inhibition blocks NMDA induced thermal hyperalgesia and produces antinociception in the formalin test in rats. Pain 54: 291–300
Eisenberg E, Lacross S, Strassman AM (1994) The effects of the clinically tested NMDA receptor antagonist memantine on carrageenan-induced thermal hyperalgesia in rats. Eur J Pharmacol 255: 123–129
Laird JMA, Mason GS, Webb J, Hill RG, Hargreaves RJ (1996) Effects of a partial agonist and a full antagonist acting at the glycine site of the NMDA receptor on inflammation-induced mechanical hyperalgesia in rats. Br J Pharmacol 117: 1487–1492
Ren K, Dubner R (1993) NMDA receptor antagonists attenuate mechanical hyperalge-sia in rats with unilateral inflammation of the hindpaw. Neurosci Lett 163: 19–21
Haley JE, Dickenson AH, Schachter M (1992) Electrophysiological eviedence for a role of nitric oxide in prolonged chemical nociception in the rat. Neuropharmacol 31: 251–258
Dickenson AH (1991) Recent advances in the physiology and pharmacology of pain: plasticity and its implications for clinical analgesia. J Psychopharmacol 5: 342–351
Bredt DS, Snyder SH (1989) Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA 86: 9030–9033
Yamamoto T, Shimoyama N, Mizuguchi T (1993) The effects of morphine, MK-801, an NMDA antagonist, and CP-96,345, an NK1 antagonist, on the hyperesthesia evoked by carrageenan injection in the rat hindpaw. Anesthesiology 78: 124–133
Handy RLC, Harb HL, Wallace P, Gaffen ZA, Whitehead KJ, Moore PK (1996) Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM) in vitro; antinociceptive and cardiovascular effects. Br J Pharmacol 119: 423–431
Semos ML, Headley PM (1994) The role of nitric oxide in spinal nociceptive reflexes in rats with neurogenic and non-neurogenic peripheral inflammation. Neuropharmacol 33: 1487–1497
Handy RLC, Moore PK (1998) Effect of selective inhibitors of neuronal nitric oxide synthase on mechanical and thermal hyperalgesia in the rat. Neuropharmacol 37: 37–43
Meller ST, Cummings CP, Traub RJ, Gebhart GF (1994a) The role of nitric oxide in the development and maintenance of the hyperalgesia produced by intraplantar injection of carrageenan in the rat. Neuroscience 60: 367–374
Minami T, Nishiara I, Seiji I, Sakamoto K, Hyodo M, Hayaishi O (1995) Nitric oxide mediates allodynia induced by intrathecal administration of prostaglandin E2 or prostaglandin Fla in conscious mice. Pain 61: 285–290
Minami T, Uda R, Horiguchi S, Ho S, Hyodo M, Hayaishi O (1992) Allodynia evoked by intrathecal administration of prostaglandin-F2-alpha to conscious mice. Pain 50: 223–229
Przewlocka R, Machelska H, Przewlocka B (1994) Modulation of morphine and cocaine effects by inhibition of nitric oxide synthase. Regulatory Peptides 51: 75–76
Shibuta S, Mashimo T, Ohara A, Zhang P, Yoshiya I (1995) Intracerebroventricular administration of a nitric oxide-releasing compound, NOC-18, produces thermal hyperalgesia in rats. Neurosci Lett 187: 103–106
Shibuta S, Mashimo T, Zhang P, Ohara A,Yoshiya I (1996) A new nitric oxide donor, NOC-18, exhibits a nociceptive effect in the rat formalin model. J Neurological Sci 141: 1–5
Garthwaite J, Southam E, Boulton CL, Nielson EB, Schmidt K, Mayer B (1995) Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]Oxadiazolo(4,3-a]quinoxalinone. Mol Pharmacol 48: 184–188
Garry MG, Richardson JD, Hargreaves KM (1994) Carrageenan-induced inflammation alters the content of I-cGMP and I-cAMP in the dorsal horn of the spinal cord. Brain Res 646: 135–139
Igwe OJ, Ning L (1994) Regulation of the second messanger systems in the rat spinal cord during prolonged inflammation. Pain 58: 63–75
Persson MG, Hedqvist P, Gustafsson LE (1991) Nerve-induced tachykinin-mediated vasodilation in skeletal muscle is dependant on nitric oxide formation. Eur J Pharmacol 205: 295–301
Radhakrishnan V, Yashpal K, Huichan CWY, Henry JL (1995) Implication of a nitric oxide synthase mechanism in the action of substance P - L-NAME blocks thermal hyperalgesia induced by endogenous and exogenous substance P in the rat. Eur J Neurosci 7: 1920–1925
Radhakrishnan V, Henry JL (1993) L-NAME blocks responses to NMDA, substance P and noxious cutaneous stimuli in cat dorsal horn. Neuroreport 4: 323–326
Murase K, Ryu PD, Radic M (1986) Substance P augments a persistent slow inward calcium-sensitive current in coltage clamped spinal dorsal horn neurons of the rat. Brain Res 365: 369–376
Womack MD, MacDermott AB, Jessell TM (1988) Sensory transmitters regulate intracellular calcium in dorsal horn neurones. Nature 334: 351–353
Callsencencic P, Mense S (1997) Expression of neuropeptides and nitric oxide synthase in neurones innervating the inflamed rat urinary bladder. J Autonomic Nervous Sys 65: 33–44
Rice ASC (1995) Topical spinal administration of a nitric oxide synthase inhibitor prevents the hyper-reflexia associated with a rat model of persistent visceral pain. Neurosci Lett 187: 111–114
Meller ST, Dykstra C, Grzybycki D, Murphy S, Gebhart GF (1994b) The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat. Neuropharmacol 33: 1471–1478
Duarte IDG, Lorenzetti BB, Ferreira SH (1990) Peripheral analgesia and activation of the nitric oxide — cyclic GMP pathway. Eur J Pharmacol 186: 289–293
Dray A (1995) Inflammatory mediators of pain. Br J Anaesthesia 75: 125–131
Kawabata A, Manabe S, Manabe Y, Takagi H (1994) Effect of topical administration of L-arginine on formalin-induced nociception in the mouse — a dual role of peripherally formed NO in pain modulation. Br J Pharmacol 112: 547–553
Holthusen H, Arndt JO (1994) Nitric oxide evokes pain in humans on intracutaneous injection. Neurosci Lett 165: 71–74
Zhou ST, Bonsera L, Carlton SM (1996) Peripheral administration of NMDA, AMPA or Ka results in pain behaviors in rats. Neuroreport 7: 895–900
Westlund KN, Lawand NB, Willis WD (1995) Soc Neurosci Abst 21: 1173
Lawand NB, Willis WD, Westlund KN (1997) Blockade of joint inflammation and secondary hyperalgesia by L-NAME, a nitric oxide synthase inhibitor. Neuroreport 8: 895–899
Jansco G, Kiraly E, Jansco-Gabor A (1977) Pharmacologically-induced selective degeneration of chemoreceptive primary sensory neuron. Nature 270: 741–743
Lembeck F, Holzer P (1979) Substance P as a neurogenic mediator of antidromic vasodilatation and neurogenic plasma extravasation. Naunyn-Schmied Arch Pharmacol 310: 175–183
Hughes SR, Brain SD (1994) Nitric-oxide dependent release of vasodilator quantities of calcitonin gene-related peptide from capsaicin-sensitive nerves in rabbit skin. Br J Pharmacol 111: 425–430
Kajekar R, Moore PK, Brain SD (1995) An essential role of nitric oxide in neurogenic inflammation: evidence for an endothelial-independent mechanism. Circ Res 76: 441–447
Lippe IT, Stabentheiner A, Holzer P (1993) Participation of nitric-oxide in the mustard oil-induced neurogenic inflammation of the rat paw skin. Eur J Pharmacol 232: 113–120
Nussler AK, Billiar TR (1993) Inflammation, immunoregulation and inducible nitric oxide synthase. J Leukocyte Biol 2: 171–178
Stefanovicracic M, Stadler J, Evans CH (1993) Nitric oxide and arthritis. Arthritis Rheum 36: 1036–1044
Hughes SR, Williams TJ, Brain SD (1990) Evidence that endogenous nitric oxide mod-ulates oedema formation induced by substance P. Eur J Pharmacol 191: 481–484
Richard V, Tanner FC, Tschudi M, Luscher TF (1990) Different activation of L-arginine pathway by bradykinin, serotonin and clonidine in coronary arteries. Am J Physiol 259: H1433–1439
Aisaka K, Gross SS, Griffith OW, Levi R (1989) NG-methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea-pig: does nitric oxide regulate blood pressure in vivo? Biochem Biophys Res Commun 160: 881–6
Gardiner SM, Compton AM, Bennett T, Palmer RMJ, Moncada S (1990) Regional haemodynamic changes following prolonged infusion of N(G) monomethyl-L-arginine methyl ester in conscious Brattleboro rats. Eur J Pharmacol 213: 449–451
Radich A, Maixner W (1984) Interactions between cardiovascular and pain regulatory systems. Neurosci Behav Rev 8: 343–367
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Basel AG
About this chapter
Cite this chapter
Handy, R.L.C. (1999). Nitric oxide and inflammatory pain. In: Brain, S.D., Moore, P.K. (eds) Pain and Neurogenic Inflammation. Progress in Inflammation Research. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8753-3_5
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8753-3_5
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9758-7
Online ISBN: 978-3-0348-8753-3
eBook Packages: Springer Book Archive